Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hydrocephalus 1Headache 1Gallbladder Neoplasms 1Female Breast Carcinoma 1Epilepsy 1Disease Progression 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Brain Edema 1Abdominal Neoplasms 1

Interventions

Dexmedetomidine 3Cabergoline 3pegvisomant 1pasireotide 1lanreotide 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Propofol 1Prednisone 1Octreotide 1Ibuprofen 1Hydrocortisone 1Hormone Replacement Therapy 1Cefdinir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pituitary Neoplasms × Sevoflurane × Clear all
NCT05822817 2025-06-08

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

Peking Union Medical College Hospital

Phase 4 Completed
252 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡